FMAEN1
WST icon

Fund Management at Engine No 1’s West Pharmaceutical WST Stock Holding History

Fund Management at Engine No 1’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,056
Closed -$396K – 421
2023
Q3 		$396K Buy
1,056
+90
+9% +$34.8K 0.06% 282
2023
Q2 		$369K Buy
966
+68
+8% +$24.3K 0.07% 289
2023
Q1 		$311K Buy
+898
New +$262K 0.06% 304
2022
Q3 		– Sell
-748
Closed -$226K – 352
2022
Q2 		$226K Buy
748
+121
+19% +$39.4K 0.06% 312
2022
Q1 		$258K Buy
+627
New +$245K 0.06% 290

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fund Management at Engine No 1's WST Position: Q4 2023 in Review

Fund Management at Engine No 1 sold out of West Pharmaceutical (WST) in Q4 2023, closing a stake of 1,056 shares — an estimated $396K sold.

Fund Management at Engine No 1 first reported a position in WST in Q1 2022 and held it in 5 quarters. The position peaked at $396K in Q3 2023. 782 funds tracked by Wall St. Rank hold WST as of Q4 2023.

  • Fund Management at Engine No 1 reported no remaining West Pharmaceutical position as of Q4 2023 after selling out during the quarter.
  • Fund Management at Engine No 1 sold 1,056 West Pharmaceutical shares in Q4 2023, an estimated $396K.
  • Fund Management at Engine No 1 first reported a position in West Pharmaceutical in Q1 2022 and held it in 5 quarters.
  • Fund Management at Engine No 1's West Pharmaceutical position peaked at $396K in Q3 2023.
  • 782 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2023.

Based on Fund Management at Engine No 1's 13F filing for Q4 2023.